Philippines: DOH Advisory Re: Temporary 60-Working Day Suspension of AO 2024-0016 on New FDA Fees and Charges June 13, 2025
Philippines: Department of Health approves the recommendation of Food and Drug Administration to temporarily suspend New Regulatory Fees. June 2, 2025
Philippines: Draft for Comments || Guidelines on the Recall of Authorized Health Products Regulated by the Food and Drug Administration April 7, 2025
Philippines: FDA Temporarily Suspends CDRRHR Telephone Lines Due to Facility Maintenance March 21, 2025
Philippines: Notice of Virtual Public Consultation on Good Storage and Distribution Practices for Medical Devices March 14, 2025
Philippines: Reiteration of Contact Details and Process for Feedback, Complaints, and Specific Concerns to the Food and Drug Administration March 14, 2025
Philippines: Interim Extension of Renewal Application Filing Period for License to Operate (LTO) March 5, 2025
Philippines: FDA Introduces Over-the-Counter (OTC) Payment System for All Applications and Transactions February 14, 2025
Philippines: Temporary Suspension of Pre-Assessment Fees for Select FDA Applications Amid Implementation of AO No. 2024-0016 February 10, 2025
Philippines: Implementation Guidelines on the New Schedule of Fees and Charges by the Food and Drug Administration December 19, 2024
Philippines: FDA Issues Administrative Order No. 2024-0015 on Updated Regulations for Health Product Establishments December 12, 2024
Philippines: FDA Concludes Pilot Implementation of eServices Portal for CMDN Applications in NCR December 12, 2024
Philippines: PFDA Shares the Guidelines for the Pilot Implementation of the FDA eServices Portal System for the Initial Application of CMDN within the National Capital Region (NCR) August 14, 2024
